Scope: Comprehensive review of ANGPTL3 inhibition as a therapeutic strategy to reduce triglyceride-rich lipoproteins and residual cardiovascular risk Therapeutic approaches discussed: Monoclonal antibodies (e.g., evinacumab) RNA-based therapies (ASOs and siRNA: vupanorsen, zodasiran, solbinsiran) Emerging gene-editing strategies (CRISPR/base editing) Key message: Targeting ANGPTL3 provides robust reductions in triglycerides, apoB-containing lipoproteins, and non-HDL cholesterol, independently of the LDL receptor Clinical relevance: Positions ANGPTL3 inhibition as a next-generation approach for managing mixed dyslipidemia and lipid-related residual risk beyond LDL-C Laura Schreier Natalia Nardelli European Atherosclerosis Society To view or add a comment, sign in Tipping the Scale in MASH: The TZD vs
Ozempic is FDA-approved for type 2 diabetes, so Anthem covers it for that indication regardless of employer benefit design
How quickly will I notice hormonal improvements on semaglutide
Table of Contents Glutathione is an essential antioxidant that helps combat various health issues ranging from chronic diseases to skin problems
It works faster than water alone and comes in a variety of flavors, so staying hydrated feels less like a chore, and more like a smart part of your daily routine
That, to my understanding, caused a severe setback to the whole- Craig: Sure
